原文： Antibiotics • SNZCBI piloted the use of long-acting antibiotics in the treatment of giant pandas with the Zoo’s adult male giant panda Tian Tian; an upcoming study with Chinese colleagues will look at a population conservation model. o SNZCBI developed a long-acting antibiotic pharmacokinetic profile and conducted a study of how the drug was absorbed, metabolized and excreted over the course of Tian Tian’s treatment; in the first profile the antibiotic maintained high levels for more than 12 days, which is close to the duration of 14 days reported in the domestic dog and cat. • Testing long-acting antibiotics has direct implications for giant pandas in human care as well as pandas being prepared for reintroduction. Chinese colleagues can safely administer long-acting antibiotics to giant pandas ahead of release to the wild when there is no opportunity for follow up treatment. This is also a critical tool for vets who treat injured wild pandas in the field. Canine Distemper • Giant pandas are particularly susceptible to canine distemper, a viral disease most domestic dogs are vaccinated against. Following the death of several giant pandas in China from canine distemper, a new type of vaccine initially developed for the domestic ferret was employed to stimulate immunity but not cause illness in giant pandas. Due to the potential enormous contribution to conservation efforts, the Zoo agreed to test the vaccine on giant pandas Mei Xiang and Tian Tian. This involved administering the vaccine and monitoring titers in the blood. Based on data known from domestic carnivores, the vaccine is considered to provide protection to giant pandas against disease caused by the canine distemper virus. The published 2007 study on testing the distemper vaccine is now the foundation of vaccine protocols utilized worldwide for giant pandas. Cardiac Disease • One of the leading causes of death in giant pandas is cardiac disease. SNZCBI’s Global Health team is currently researching the use of implantable loop recorders in giant pandas to monitor cardiac disease and provide early warning signs so treatment can be initiated. Hepatozoan • Hepatozoan, a parasite transmitted by ticks, was found in the Zoo’s giant pandas in 2005. Working with Chinese colleagues, SNZCBI scientists determined it was a novel parasite brought to the United States from China. This parasite has not had any negative impact on the Zoo’s pandas. SNZCBI published research in 2019 and is working towards a clinical study to investigate more thoroughly in China.
那么搜搜看国内具体的报道，说的是那伙人是已经去大熊猫保护基地直接拉横幅、现场骚扰熊猫研究专家、报假警了。让你更失望的是，报道里只说了编造华盛顿动物园虐待熊猫，但没提孟菲斯动物园。
但既然有些人想挑事，那我也只能说智商是个好东西。新闻里的造谣案例是对美香和添添的境遇造谣，而美香和添添是DC动物园的熊猫。
海外网友针对的熊猫被虐是孟菲斯动物园的熊猫丫丫
丫丫有没有受虐，回中国前后的对比在那摆着，真以为大家看不懂？
是的，而且时间线也对不上
根据警方通报，这个犯罪集团的造谣活动始于2023年6月，而丫丫在2023年4月就回中国了。所以这个造谣事件跟海外网友针对的丫丫事件毫无关系。有些人就是在那想造谣浑水摸鱼。
说句不好听的话，楼主这种性质的造谣，跟那些被逮的犯罪分子的造谣，本质其实是一样的。
抗生素 - SNZCBI生物技术研究所在动物园成年雄性大熊猫 “添添 ”身上试行使用长效抗生素治疗大熊猫。 o SNZCBI开发了长效抗生素的药代动力学特征，并对 “添添 ”治疗过程中药物的吸收、代谢和排泄情况进行了研究；在第一个特征中，抗生素在超过12天的时间内保持高水平，接近家犬和家猫14天的持续时间。 - 测试长效抗生素对人类照料的大熊猫以及准备放归的大熊猫都有直接影响。中国同事可以在大熊猫被放归野外之前，在没有后续治疗机会的情况下，安全地给大熊猫使用长效抗生素。这也是兽医在野外治疗受伤野生大熊猫的重要工具。 犬瘟热 - 大熊猫特别容易感染犬瘟热，而大多数家犬都接种过这种病毒性疾病的疫苗。在中国有几只大熊猫死于犬瘟热后，一种最初为家养雪貂开发的新型疫苗被用于激发免疫力，但不会导致大熊猫发病。由于这种疫苗可能对大熊猫保护工作做出巨大贡献，动物园同意在大熊猫 “美香 ”和 “添添 ”身上进行试验。这包括注射疫苗和监测血液中的滴度。根据已知的家养食肉动物的数据，该疫苗可保护大熊猫免受犬瘟热病毒引起的疾病。2007 年发表的犬瘟热疫苗测试研究现已成为全球大熊猫疫苗接种方案的基础。
又打鸡血了 算了吧 好好过年不好吗
Antibiotics • SNZCBI piloted the use of long-acting antibiotics in the treatment of giant pandas with the Zoo’s adult male giant panda Tian Tian; an upcoming study with Chinese colleagues will look at a population conservation model. o SNZCBI developed a long-acting antibiotic pharmacokinetic profile and conducted a study of how the drug was absorbed, metabolized and excreted over the course of Tian Tian’s treatment; in the first profile the antibiotic maintained high levels for more than 12 days, which is close to the duration of 14 days reported in the domestic dog and cat. • Testing long-acting antibiotics has direct implications for giant pandas in human care as well as pandas being prepared for reintroduction. Chinese colleagues can safely administer long-acting antibiotics to giant pandas ahead of release to the wild when there is no opportunity for follow up treatment. This is also a critical tool for vets who treat injured wild pandas in the field. Canine Distemper • Giant pandas are particularly susceptible to canine distemper, a viral disease most domestic dogs are vaccinated against. Following the death of several giant pandas in China from canine distemper, a new type of vaccine initially developed for the domestic ferret was employed to stimulate immunity but not cause illness in giant pandas. Due to the potential enormous contribution to conservation efforts, the Zoo agreed to test the vaccine on giant pandas Mei Xiang and Tian Tian. This involved administering the vaccine and monitoring titers in the blood. Based on data known from domestic carnivores, the vaccine is considered to provide protection to giant pandas against disease caused by the canine distemper virus. The published 2007 study on testing the distemper vaccine is now the foundation of vaccine protocols utilized worldwide for giant pandas. Cardiac Disease • One of the leading causes of death in giant pandas is cardiac disease. SNZCBI’s Global Health team is currently researching the use of implantable loop recorders in giant pandas to monitor cardiac disease and provide early warning signs so treatment can be initiated. Hepatozoan • Hepatozoan, a parasite transmitted by ticks, was found in the Zoo’s giant pandas in 2005. Working with Chinese colleagues, SNZCBI scientists determined it was a novel parasite brought to the United States from China. This parasite has not had any negative impact on the Zoo’s pandas. SNZCBI published research in 2019 and is working towards a clinical study to investigate more thoroughly in China.